Myxovirus Resistance Protein A Is a Useful Additional Histological Marker in Suspected Cutaneous Lupus Erythematosus

被引：3

作者：

Lambers, Wietske M. ^{[1
]}

Diercks, Gilles F. H. ^{[2
]}

Homan, Femke M. ^{[3
]}

Doornbos-van der Meer, Berber ^{[1
]}

Bootsma, Hendrika ^{[1
]}

Westra, Johanna ^{[1
]}

de Leeuw, Karina ^{[1
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Hanzepl 1, NL-9700 RB Groningen, Netherlands

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Hanzepl 1, NL-9700 RB Groningen, Netherlands

[3] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Hanzepl 1, NL-9700 RB Groningen, Netherlands

来源：

ACTA DERMATO-VENEREOLOGICA | 2020年 / 100卷

关键词：

EXPRESSION;

D O I：

10.2340/00015555-3587

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune skin disease. Since the clinical picture can be quite heterogeneous, histological confirmation is of importance. However, the typical histological features, including an interface dermatitis, are not at all specific. As CLE is an interferon (IFN)-driven disease, IFN-related markers, such as myxovirus resistance protein A (MxA), could be helpful in the diagnostic process. This can be illustrated by 2 cases.

引用

页数：2

共 50 条

[21] The CLASI is a useful clinical instrument to measure activity and damage in patients with cutaneous lupus erythematosus
Bonilla-Martinez, Z. L.
Albrecht, J.
Taylor, L.
Okawa, J.
Werth, V. P.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 47 - 47
[22] ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: ARE THEY USEFUL?
Kumar, Rajesh
Cavazzana, Ilaria
Fredi, Micaela
Ottaviani, Roberta
Tincani, Angela
Franceschini, Franco
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1719 - 1719
[23] ANTICARDIOLIPIN ANTIBODIES IN CUTANEOUS LUPUS-ERYTHEMATOSUS - OCCURRENCE AND SIGNIFICANCE AS A MARKER FOR VASCULAR INVOLVEMENT
TEBBE, B
ORFANOS, CE
HAUTARZT, 1992, 43 (03): : 130 - 133
[24] Expression of Myxovirus-Resistance Protein a: A Possible Marker of Muscular Disease Activity in Juvenile Dermatomyositis
Soponkanaporn, Sirisucha
Deakin, Claire
Marshall, Lucy
Johnson, Cerise
Schutz, Peter
Wedderburn, Lucy R.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[25] CUTANEOUS MANIFESTATIONS OF LUPUS-ERYTHEMATOSUS - A CLINICAL AND HISTOLOGICAL STUDY USING MONOCLONAL-ANTIBODIES
MCHUGH, NJ
MADDISON, PJ
MACLEOD, TIS
DEAN, SG
JAMES, IE
GOULDING, NJ
TAN, RSH
BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 : 7 - 7
[26] Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus
Kalinska-Bienias, Agnieszka
Kowalczyk, Emilia
Bienias, Piotr
Gala, Kamila
Jagielski, Pawel
Kowalewski, Cezary
POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (02): : 274 - 280
[27] Lymphocyte sensitivity assay as a marker for glucocorticoid resistance in lupus: report of two sisters with systemic lupus erythematosus
Fajardo-Hermosillo, L. D.
Rodriguez-Navedo, Y.
Nadal, A. J.
Vila, L. M.
LUPUS, 2014, 23 (01) : 88 - 92
[28] CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study
Niederkorn, Anna
Fruehauf, Julia
Schwantzer, Gerold
Wutte, Nora
Painsi, Clemens
Werner, Stefan
Stradner, Martin
Berghold, Andrea
Hermann, Josef
Aberer, Elisabeth
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2018, 310 (06) : 485 - 493
[29] SIMULTANEOUS OCCURRENCE OF SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS AND SWEET SYNDROME - A MARKER OF SJOGREN SYNDROME
LEVENSTEIN, MM
FISHER, BK
FISHER, LL
PRUZANSKI, W
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (09) : 640 - 643
[30] CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study
Anna Niederkorn
Julia Frühauf
Gerold Schwantzer
Nora Wutte
Clemens Painsi
Stefan Werner
Martin Stradner
Andrea Berghold
Josef Hermann
Elisabeth Aberer
Archives of Dermatological Research, 2018, 310 : 485 - 493

← 1 2 3 4 5 →